Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (181-190 of 242) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Neuro-Oncology|September 30, 2016
Pediatric low-grade gliomas: implications of the biologic eraRoger J Packer, Stephan Pfister, Eric Bouffet, et al.
Nature Genetics|October 28, 2017
Erratum: DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeatsDavid Brocks, Christopher R Schmidt, Michael Daskalakis, et al.
Nature Genetics|June 13, 2017
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeatsDavid Brocks, Christopher R Schmidt, Michael Daskalakis, et al.
Neuro-Oncology|December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trialKarsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
The Journal of Clinical Investigation|October 16, 2025
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcomaCornelius M Funk, Anna C Ehlers, Martin F Orth, et al.
Pageof 25

Showing results (181-190 of 242) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Neuro-Oncology|September 30, 2016
Pediatric low-grade gliomas: implications of the biologic eraRoger J Packer, Stephan Pfister, Eric Bouffet, et al.
Nature Genetics|October 28, 2017
Erratum: DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeatsDavid Brocks, Christopher R Schmidt, Michael Daskalakis, et al.
Nature Genetics|June 13, 2017
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeatsDavid Brocks, Christopher R Schmidt, Michael Daskalakis, et al.
Neuro-Oncology|December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trialKarsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
The Journal of Clinical Investigation|October 16, 2025
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcomaCornelius M Funk, Anna C Ehlers, Martin F Orth, et al.
Pageof 25